Geoffrey B. Pardo - 09 Feb 2026 Form 4 Insider Report for SpyGlass Pharma, Inc. (SGP)

Reporting relationship: Director
Issuer ticker: SGP
Reported as of: 09 Feb 2026
Net transaction value: +$5,000,000
SEC form: 4
Accepted by SEC: 11 Feb 2026, 16:09:36 UTC
Prior SEC filing: 05 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Brian Aukshunas, as Attorney-in-Fact

Key filing fact

Geoffrey B. Pardo filed Form 4 for SpyGlass Pharma, Inc. (SGP) on 11 Feb 2026.

Key facts

This page summarizes Geoffrey B. Pardo's Form 4 filing for SpyGlass Pharma, Inc. (SGP).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 11 Feb 2026, 16:09.

Change

Previous filing in this sequence was filed on 05 Feb 2026.
Current net transaction value: +$5,000,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001753143 Primary reporting owner

Pardo Geoffrey B

Relationship: Director
Address: C/O SPYGLASS PHARMA, INC., 27061 ALISO CREEK RD., SUITE 100, ALISO VIEJO
Signature: /s/ Brian Aukshunas, as Attorney-in-Fact
Signature date: 11 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGP transaction

Common Stock

Conversion of derivative security

Transaction value: $0
Shares: +1,875,013
Change %
Price: $0.000000
Shares after: 1,875,013
Date: 09 Feb 2026
Ownership: See footnote
Footnotes: F1, F2

SGP transaction

Common Stock

Purchase

Transaction value: $5,000,000
Shares: +312,500
Change %: +17%
Price: $16.00
Shares after: 2,187,513
Date: 09 Feb 2026
Ownership: See footnote
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SGP transaction Derivative

Series D Preferred Stock

Conversion of derivative security

Transaction value
Shares: -1,875,013
Change %: -100%
Price
Shares after: 0
Date: 09 Feb 2026
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 1,875,013
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

All shares of the preferred stock, par value $0.00001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.

Footnote F2

Shares held by Cooperatieve Gilde Healthcare VG VI U.A. (Gilde). Gilde Healthcare VG VI Management B.V. (Gilde Healthcare Management) is the manager of Gilde and has sole voting and dispositive power with respect to the shares held by Gilde. Gilde Healthcare Management is owned by Gilde Healthcare Holding B.V. and managed by Edwin de Graaf and Pieter Van der Meer. The Reporting Person is the President and General Partner of Gilde Healthcare US Inc. and may be deemed to share voting and dispositive power with respect to the shares held of record by Gilde. Each of Mr. de Graaf, Mr. Van der Meer and the Reporting Person disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares.